Table 1 Best CDKi’s identified in this study for selective target engagement in live cells.
CDK | Compound | On target potencya | Collateral CDK (potency) |
---|---|---|---|
CDK2 | NU6102 | 290 nM | STb |
CDK3 | RO-3306 | 200 nM | CDK7 (690 nM) |
CDK4/6 | Palbociclib | 10 nM/2 nM | STb |
CDK4/6 | Ribociclib | 29 nM/31 nM | STb |
CDK7 | THZ1 | 90 nM | CDK11a (300 nM) |
CDK7 | BS-181 | 470 nM | STb |
CDK9 | BAY-1251152 | 9 nM | STb |
CDK9 | Atuveciclib | 150 nM | STb |
CDK8/19 | CCT251545 | 6 nM/6 nM | STb |
CDK8/19 | CCT251545 analog | 6 nM/10 nM | STb |
CDK8/19 | BMS-265246 | 0.7 nM/1.5 nM | CDK3 (10 nM) |
CDK8/19 | K08361 | 3 nM/1.4 nM | CDK7 (63 nM) |
CDK12 | THZ531 | 770 nM | STb |